Nectar Lifesciences Limited announced that its board of directors, in a meeting held on January 23, 2026, approved several key decisions. The board sanctioned the adoption of a new Memorandum of Association (MOA), which includes expanding the company's business activities to encompass construction, development, and real estate operations, subject to shareholder approval. Additionally, the board appointed M/s. VDR & Associates, Chartered Accountants, as the Internal Auditor for the financial years 2025-26 and 2026-27. The company will seek shareholder approval for the amended MOA through a postal ballot process. The cut-off date for determining eligible members for this process is January 23, 2026. The board meeting commenced at 3:00 P.M. IST and concluded at 4:30 P.M. IST.
